314 related articles for article (PubMed ID: 31108832)
1. Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance.
Frame FM; Maitland NJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108832
[TBL] [Abstract][Full Text] [Related]
2. Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium.
Archer LK; Frame FM; Maitland NJ
J Steroid Biochem Mol Biol; 2017 Feb; 166():68-83. PubMed ID: 27185499
[TBL] [Abstract][Full Text] [Related]
3. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
Glinsky GV
Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer stem cells: a new target for therapy.
Maitland NJ; Collins AT
J Clin Oncol; 2008 Jun; 26(17):2862-70. PubMed ID: 18539965
[TBL] [Abstract][Full Text] [Related]
5. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer.
Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
7. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.
Chang G; Xu S; Dhir R; Chandran U; O'Keefe DS; Greenberg NM; Gingrich JR
Clin Cancer Res; 2010 Nov; 16(22):5390-401. PubMed ID: 21062931
[TBL] [Abstract][Full Text] [Related]
8. A basal stem cell signature identifies aggressive prostate cancer phenotypes.
Smith BA; Sokolov A; Uzunangelov V; Baertsch R; Newton Y; Graim K; Mathis C; Cheng D; Stuart JM; Witte ON
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6544-52. PubMed ID: 26460041
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
10. Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.
Liu X; Chen X; Rycaj K; Chao HP; Deng Q; Jeter C; Liu C; Honorio S; Li H; Davis T; Suraneni M; Laffin B; Qin J; Li Q; Yang T; Whitney P; Shen J; Huang J; Tang DG
Oncotarget; 2015 Sep; 6(27):23959-86. PubMed ID: 26246472
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer.
Prudnikova TY; Soulitzis N; Kutsenko OS; Mostovich LA; Haraldson K; Ernberg I; Kashuba VI; Spandidos DA; Zabarovsky ER; Grigorieva EV
Cancer Med; 2013 Oct; 2(5):654-61. PubMed ID: 24403231
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.
Singh S; Chitkara D; Mehrazin R; Behrman SW; Wake RW; Mahato RI
PLoS One; 2012; 7(6):e40021. PubMed ID: 22768203
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of cancer stem cells in prostate cancer.
Banerjee P; Kapse P; Siddique S; Kundu M; Choudhari J; Mohanty V; Malhotra D; Gosavi SW; Gacche RN; Kundu GC
Cancer Biol Med; 2023 Jun; 20(6):401-20. PubMed ID: 37282627
[TBL] [Abstract][Full Text] [Related]
16. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer.
Singh N; Ramnarine VR; Song JH; Pandey R; Padi SKR; Nouri M; Olive V; Kobelev M; Okumura K; McCarthy D; Hanna MM; Mukherjee P; Sun B; Lee BR; Parker JB; Chakravarti D; Warfel NA; Zhou M; Bearss JJ; Gibb EA; Alshalalfa M; Karnes RJ; Small EJ; Aggarwal R; Feng F; Wang Y; Buttyan R; Zoubeidi A; Rubin M; Gleave M; Slack FJ; Davicioni E; Beltran H; Collins C; Kraft AS
Nat Commun; 2021 Dec; 12(1):7349. PubMed ID: 34934057
[TBL] [Abstract][Full Text] [Related]
17. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
18. Histone modifications, stem cells and prostate cancer.
Crea F; Clermont PL; Mai A; Helgason CD
Curr Pharm Des; 2014; 20(11):1687-97. PubMed ID: 23888964
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
[TBL] [Abstract][Full Text] [Related]
20. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development.
Bianco-Miotto T; Chiam K; Buchanan G; Jindal S; Day TK; Thomas M; Pickering MA; O'Loughlin MA; Ryan NK; Raymond WA; Horvath LG; Kench JG; Stricker PD; Marshall VR; Sutherland RL; Henshall SM; Gerald WL; Scher HI; Risbridger GP; Clements JA; Butler LM; Tilley WD; Horsfall DJ; Ricciardelli C;
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2611-22. PubMed ID: 20841388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]